Sir Michael Brady
Interim President, Mohamed bin Zayed University of Artificial Intelligence
Sir Michael Brady was Associate Director of the AI Laboratory at MIT from 1980-1985, leaving to take up the newly created Professorship of Information Engineering, University of Oxford, which he held from 1985-2010. Upon “retirement”, he was appointed Emeritus Professor of Oncological Imaging in the Department of Oncology of the University of Oxford. He is the author of over 500 articles and 50 patents in computer vision, robotics, medical image analysis, and artificial intelligence, and the author or editor of ten books. He has been elected a Fellow of the Royal Society, Fellow of the Royal Academy of Engineering, Membre Associé Étranger of the Académie des Sciences, Honorary Fellow of the Institution of Engineering and Technology, Fellow of the Institute of Physics, Fellow of the Academy of Medical Sciences, and Fellow of the British Computer Society. He was awarded the Royal Academy of Engineering Whittle Medal, the IET Faraday Prize, and the Henry Dale Prize. Sir Michael has founded successful spin-out companies, primarily in medical image analysis: Volpara Healthcare Technologies; Perspectum Diagnostics; ScreenPoint Medical bv; Optellum; Mirada Medical; and formerly Mirada Solutions; and the Guidance Group (Monitoring, Industrial, and Marine Divisions). He was a Director of Oxford Instruments plc from 1995-2014.